Compare WHD & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHD | BLLN |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2018 | N/A |
| Metric | WHD | BLLN |
|---|---|---|
| Price | $52.58 | $79.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $56.33 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 884.8K | 317.9K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 18.99 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,079,051,000.00 | N/A |
| Revenue This Year | $44.76 | $45.96 |
| Revenue Next Year | $5.51 | $30.11 |
| P/E Ratio | $282.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.30 | $61.96 |
| 52 Week High | $59.25 | $138.70 |
| Indicator | WHD | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 50.53 |
| Support Level | $43.91 | $64.99 |
| Resistance Level | $59.02 | $83.20 |
| Average True Range (ATR) | 1.85 | 6.88 |
| MACD | 0.55 | -0.07 |
| Stochastic Oscillator | 76.51 | 46.34 |
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.